Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hearts and Minds trial in major depressive disorder
ACTRN12623000611628Phase 3Recruiting
- Sponsor
- Deakin University
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in major depressive disorder (MDD) comparing Adjunctive atorvastatin plus usual care, Adjunctive metformin plus usual care and Placebo plus usual care (3 arms). Started Oct 2023; status: recruiting.
02
Drugs
atorvastatinmetformin
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ACTRN12623000611628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623000611628.